Cancer reports (Hoboken, N.J.) · 2025
Development of Symptomatic Bone Marrow Metastasis After Complete Response to Immunochemotherapy in Squamous Cell Lung Carcinoma.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Momose Akari, Koizumi Tomonobu, Takei Risa, Waki Yutaro, Midorikawa Hajime, Kitagawa Nami, Kawakami Fumihiro, Ohya Maki, Hamano Hideaki
Аннотация
INTRODUCTION: Symptomatic bone marrow metastasis in squamous cell lung cancer after achieving a complete response to immunochemotherapy has not been reported previously.
CASE PRESENTATION: A 63-year-old Japanese man was referred to our hospital for further examination of an abnormal chest radiograph. Whole-body computed tomography revealed left hilar swelling and osteolytic lesions. Bronchoscopic examination led to a diagnosis of squamous cell lung carcinoma with multiple bone metastases. He was treated with carboplatin/Nab-paclitaxel and pembrolizumab, and achieved complete response as determined by positron emission tomography with fluorodeoxyglucose-computed tomography. Despite pembrolizumab maintenance therapy for 1 year, thrombocytopenia, anemia, and leukoerythroblastosis occurred. Bone marrow biopsy revealed squamous cell carcinoma cells within fibrotic tissue, confirming the diagnosis of symptomatic bone marrow metastases. The patient died 1 month after this diagnosis.
CONCLUSION: Recurrence presenting bone marrow metastasis should be considered in patients with squamous cell lung cancer, even achieving complete response to immunochemotherapy, particularly those with bone metastases.
CASE PRESENTATION: A 63-year-old Japanese man was referred to our hospital for further examination of an abnormal chest radiograph. Whole-body computed tomography revealed left hilar swelling and osteolytic lesions. Bronchoscopic examination led to a diagnosis of squamous cell lung carcinoma with multiple bone metastases. He was treated with carboplatin/Nab-paclitaxel and pembrolizumab, and achieved complete response as determined by positron emission tomography with fluorodeoxyglucose-computed tomography. Despite pembrolizumab maintenance therapy for 1 year, thrombocytopenia, anemia, and leukoerythroblastosis occurred. Bone marrow biopsy revealed squamous cell carcinoma cells within fibrotic tissue, confirming the diagnosis of symptomatic bone marrow metastases. The patient died 1 month after this diagnosis.
CONCLUSION: Recurrence presenting bone marrow metastasis should be considered in patients with squamous cell lung cancer, even achieving complete response to immunochemotherapy, particularly those with bone metastases.